McGlone Suttner Wealth Management Inc. Sells 926 Shares of UnitedHealth Group Incorporated $UNH

Key Points

• McGlone Suttner Wealth Management Inc. sold 926 shares of UnitedHealth Group, reducing its holdings by 42.5% during the second quarter, leaving them with a total of 1,255 shares worth $391,000.
• UnitedHealth Group reported $4.08 EPS for the last quarter, missing estimates by $0.37, but its revenue increased by 12.9% year over year to $111.62 billion.
• The company declared a quarterly dividend of $2.21 per share, with an annualized basis of $8.84, reflecting a dividend yield of 2.6%.

McGlone Suttner Wealth Management Inc. decreased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 42.5% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,255 shares of the healthcare conglomerate's stock after selling 926 shares during the quarter. McGlone Suttner Wealth Management Inc.'s holdings in UnitedHealth Group were worth $391,000 at the end of the most recent quarter.

Several other large investors have also recently added to or reduced their stakes in UNH. Bayforest Capital Ltd raised its holdings in UnitedHealth Group by 685.7% in the 1st quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock valued at $29,000 after acquiring an additional 48 shares in the last quarter. Clal Insurance Enterprises Holdings Ltd raised its holdings in shares of UnitedHealth Group by 416.7% in the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate's stock worth $32,000 after buying an additional 50 shares in the last quarter. Copia Wealth Management acquired a new stake in UnitedHealth Group during the 4th quarter valued at $42,000. IAG Wealth Partners LLC acquired a new stake in UnitedHealth Group during the 1st quarter valued at $42,000. Finally, O Brien Wealth Partners LLC increased its holdings in UnitedHealth Group by 74.0% during the 1st quarter. O Brien Wealth Partners LLC now owns 87 shares of the healthcare conglomerate's stock valued at $46,000 after purchasing an additional 37 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company's stock.

UnitedHealth Group Price Performance

NYSE:UNH opened at $336.72 on Monday. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. The stock's 50-day simple moving average is $295.67 and its 200 day simple moving average is $363.56. The company has a market cap of $304.96 billion, a P/E ratio of 14.59, a P/E/G ratio of 2.20 and a beta of 0.44. UnitedHealth Group Incorporated has a 52-week low of $234.60 and a 52-week high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). The company had revenue of $111.62 billion during the quarter, compared to analyst estimates of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. UnitedHealth Group's revenue was up 12.9% compared to the same quarter last year. During the same period in the prior year, the firm posted $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, sell-side analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 23rd. Investors of record on Monday, September 15th will be issued a dividend of $2.21 per share. The ex-dividend date is Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a yield of 2.6%. UnitedHealth Group's dividend payout ratio (DPR) is presently 38.30%.

Analyst Upgrades and Downgrades

A number of research firms recently weighed in on UNH. KeyCorp dropped their price target on UnitedHealth Group from $400.00 to $350.00 and set an "overweight" rating for the company in a report on Wednesday, July 30th. Truist Financial lifted their target price on UnitedHealth Group from $310.00 to $365.00 and gave the company a "buy" rating in a research note on Tuesday, September 9th. Wells Fargo & Company lowered their target price on UnitedHealth Group from $306.00 to $267.00 and set an "overweight" rating for the company in a research note on Monday, August 4th. Bank of America boosted their price objective on UnitedHealth Group from $290.00 to $325.00 and gave the stock a "neutral" rating in a report on Monday, August 18th. Finally, Barclays boosted their price objective on UnitedHealth Group from $337.00 to $352.00 and gave the stock an "overweight" rating in a report on Thursday, September 4th. Sixteen investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have assigned a Sell rating to the company. According to MarketBeat, UnitedHealth Group has a consensus rating of "Moderate Buy" and a consensus price target of $358.95.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.